التفاصيل البيبلوغرافية
| العنوان: |
One-year survival in recipients older than 50 bridged to heart transplant with Impella 5.5 via axillary approach. |
| المؤلفون: |
Paghdar, Smit, Desai, Smruti, Ji-Min Jang, Ruiz, Jose, Malkani, Sharan, Patel, Parag, Yip, Daniel S., Leoni, Juan C., Nativi, Jose, Sareyyupoglu, Basar, Landolfo, Kevin, Si Pham, Goswami, Rohan M. |
| المصدر: |
Journal of Geriatric Cardiology; May2023, Vol. 20 Issue 5, p319-329, 11p |
| مصطلحات موضوعية: |
HEART transplantation, PATIENT selection, AGE distribution, HEMOLYSIS & hemolysins, PATIENTS, HEART assist devices, MANN Whitney U Test, SURGICAL complications, SURVIVAL rate, TREATMENT effectiveness, COMPARATIVE studies, DESCRIPTIVE statistics, ELECTRONIC health records, DATA analysis software, HEMODYNAMICS, HEART failure, TRANSPLANTATION of organs, tissues, etc., OLD age |
| مصطلحات جغرافية: |
FLORIDA |
| مستخلص: |
BACKGROUND Optimizing patients with advanced heart failure before orthotopic heart transplantation (OHT), especially in patients greater than 50 years old, is imperative to achieving successful post-transplant outcomes. Complications are well-described for patients bridged to transplant (BTT) with durable left ventricular assist device (LVAD) support. Given the lack of data available in older recipients after the recent increase in mechanical support use, we felt it crucial to report our center's one-year outcomes in older recipients after heart transplantation with percutaneously placed Impella 5.5 as a BTT. METHODS Forty-nine OHT patients were supported with the Impella 5.5 intended as a bridge between December 2019 and October 2022 at Mayo Clinic in Florida. Data were extracted from the electronic health record at baseline and during their transplant episode of care after Institutional Review Boards approval as exempt for retrospective data collection. RESULTS Thirty-eight patients aged 50 or older were supported with Impella 5.5 as BTT. Ten patients underwent heart and kidney transplantation within this cohort. The median age at OHT was 63 (58-68) years, with 32 male (84%) and six female patients (16%). Etiology was divided into ischemic (63%) and non-ischemic cardiomyopathy (37%). The baseline median ejection fraction was 19% (15-24). Most patients were in blood group O (60%), and 50% were diabetic. The average duration of support was 27 days (range 6-94). The median duration of follow-up is 488 days (185-693). For patients that have reached the 1-year follow-up timeframe (22 of 38, 58%), the 1-year post-transplant survival is 95%. CONCLUSION Our single-center data provides awareness for using the Impella 5.5 percutaneously placed axillary support device in older heart failure patients in cardiogenic shock as a bridge to transplantation. One-year survival outcomes after heart transplantation are excellent despite the older recipient's age and prolonged pre-transplant support. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Geriatric Cardiology is the property of Journal of Geriatric Cardiology and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
